| Log in

AstraZeneca India To De-list From Bourses

29 June, 2010

AstraZeneca Pharma India, Indian arm of Sweden-based AstraZeneca Pharmaceuticals AB, will de-list itself from domestic stock exchanges, BSE, NSE and Bangalore Stock Exchange. The stock price went up 20% or Rs 201 to close at all time high at Rs 1,207.05 on the BSE on Tuesday. Recently, the new regulation has been implemented making it mandatory for all listed companies to raise public shareholding to a minimum of 25%.

On Tuesday, the company’s board of directors approved a voluntary delisting offer, after the delisting proposal received on June 28, 2010 from AstraZeneca Pharmaceuticals AB, Sweden, the promoter of the Company, company said in a filing to the Bombay Stock Exchange. AstraZeneca Pharmaceuticals AB presently holds 89.99 per cent stake in AstraZeneca Pharma India.


Leave Your Comment
SEBI probing AstraZeneca Pharma India's delisting offer

SEBI probing AstraZeneca Pharma India’s delisting offer

Anuradha Verma 3 years ago
The capital markets regulator Securities and Exchange Board of India (SEBI) has...
AstraZeneca Pharma India board approves delisting offer

AstraZeneca Pharma India board approves delisting offer

TEAM VCC 4 years ago
The board of directors of AstraZeneca Pharma India Ltd, the domestic-listed arm...
AstraZeneca’s Indian arm asks for more information from parent on delisting offer

AstraZeneca’s Indian arm asks for more information from parent on delisting offer

Lohit Jagwani 4 years ago
AstraZeneca Pharma India Ltd, the domestic arm of the British-Swedish drug, ...
No Comments

AstraZeneca India To De-list From Bourses

Powered by WordPress.com VIP